Joseph G. Rajendran
Department of Radiology
University of Washington
Seattle
Washington 98195
USA
Name/email consistency: medium
- Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose. Rajendran, J.G., Gopal, A.K., Fisher, D.R., Durack, L.D., Gooley, T.A., Press, O.W. J. Nucl. Med. (2008)
- Beyond detection: novel applications for PET imaging to guide cancer therapy. Rajendran, J.G., Mankoff, D.A. J. Nucl. Med. (2007)
- Expanding role of positron emission tomography in cancer of the uterine cervix. Rajendran, J.G., Greer, B.E. J. Natl. Compr. Canc. Netw (2006)
- Hypoxia imaging-directed radiation treatment planning. Rajendran, J.G., Hendrickson, K.R., Spence, A.M., Muzi, M., Krohn, K.A., Mankoff, D.A. Eur. J. Nucl. Med. Mol. Imaging (2006)
- Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer. Rajendran, J.G., Schwartz, D.L., O'Sullivan, J., Peterson, L.M., Ng, P., Scharnhorst, J., Grierson, J.R., Krohn, K.A. Clin. Cancer Res. (2006)
- Imaging hypoxia and angiogenesis in tumors. Rajendran, J.G., Krohn, K.A. Radiol. Clin. North Am. (2005)
- Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Rajendran, J.G., Mankoff, D.A., O'Sullivan, F., Peterson, L.M., Schwartz, D.L., Conrad, E.U., Spence, A.M., Muzi, M., Farwell, D.G., Krohn, K.A. Clin. Cancer Res. (2004)
- High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes. Rajendran, J.G., Fisher, D.R., Gopal, A.K., Durack, L.D., Press, O.W., Eary, J.F. J. Nucl. Med. (2004)
- Comparison of radiation dose estimation for myeloablative radioimmunotherapy for relapsed or recurrent mantle cell lymphoma using (131)I tositumomab to that of other types of non-Hodgkin's lymphoma. Rajendran, J., Gopal, A., Durack, L., Fisher, D., Press, O., Eary, J. Cancer Biother. Radiopharm. (2004)
- [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Rajendran, J.G., Wilson, D.C., Conrad, E.U., Peterson, L.M., Bruckner, J.D., Rasey, J.S., Chin, L.K., Hofstrand, P.D., Grierson, J.R., Eary, J.F., Krohn, K.A. Eur. J. Nucl. Med. Mol. Imaging (2003)
- High-dose 166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation. Rajendran, J.G., Eary, J.F., Bensinger, W., Durack, L.D., Vernon, C., Fritzberg, A. J. Nucl. Med. (2002)
- Brain SPECT used to evaluate vasospasm after subarachnoid hemorrhage: correlation with angiography and transcranial Doppler. Rajendran, J.G., Lewis, D.H., Newell, D.W., Winn, H.R. Clin. Nucl. Med (2001)
- In-111-labeled leukocyte infection imaging: false-positive results caused by wound dressing and hematoma. Rajendran, J.G., Graham, M.M. Clin. Nucl. Med (1999)









